Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
36.08
+0.93 (2.65%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Harrow Employees
Harrow had 373 employees as of December 31, 2025. The number of employees decreased by 9 or -2.36% compared to the previous year.
Employees
373
Change (1Y)
-9
Growth (1Y)
-2.36%
Revenue / Employee
$730,035
Profits / Employee
-$13,777
Market Cap
1.34B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 373 | -9 | -2.36% | 373 | 0 |
| Dec 31, 2024 | 382 | 67 | 21.27% | 382 | 0 |
| Dec 31, 2023 | 315 | 98 | 45.16% | 315 | 0 |
| Dec 31, 2022 | 217 | 35 | 19.23% | 217 | 0 |
| Dec 31, 2021 | 182 | 57 | 45.60% | 182 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Evotec SE | 4,788 |
| Phibro Animal Health | 2,475 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,012 |
| ANI Pharmaceuticals | 970 |
| Pacira BioSciences | 829 |
HROW News
- 6 days ago - These Analysts Revise Their Forecasts On Harrow Following Q4 Results - Benzinga
- 7 days ago - Harrow to Present at Leerink Partner's 2026 Global Healthcare Conference - GlobeNewsWire
- 7 days ago - Harrow: The Post Earnings Drop Exposes The Cost Of Growth (Rating Downgrade) - Seeking Alpha
- 7 days ago - Harrow, Inc. (HROW) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Harrow Shares Collapse, Another Opportunity? - Seeking Alpha
- 8 days ago - Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication - GlobeNewsWire
- 8 days ago - Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance - GlobeNewsWire
- 21 days ago - Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 - GlobeNewsWire